ORGO vs RVTY · rev $81.0M vs P/E 42, rev $1.44B
Organogenesis Holdings Inc (ORGO) versus Revvity Inc. (RVTY) — a side-by-side from cached financials, not a winner call.
Organogenesis Holdings Inc (ORGO) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Revvity Inc. (RVTY) is a diagnostics & research company listed on US.
Latest reported ORGO revenue for 2026-06-30 was $81.0M. Net income was -$149.4M. ORGO currently screens at market cap $301.1M.
Latest reported RVTY revenue for 2026-07-05 was $1.44B. Net income was $92.5M. RVTY currently screens at market cap $11.94B and trailing P/E 41.9.
ORGO currently screens at market cap $301.1M. RVTY currently screens at market cap $11.94B and trailing P/E 41.9.
Not investment advice. Open the ORGO and RVTY stock pages for the full models.
Not investment advice.